Russell Investments Group
TMCI icon

Russell Investments Group’s Treace Medical Concepts TMCI Stock Holding History

Russell Investments Group’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.4K Sell
6,892
-2,151
-24% -$5.91K ﹤0.01% 3753
2026
Q1 		$12.1K Buy
9,043
+5,093
+129% +$10.2K ﹤0.01% 3753
2025
Q4 		$9.68K Sell
3,950
-35,301
-90% -$153K ﹤0.01% 3803
2025
Q3 		$263K Sell
39,251
-2,085
-5% -$13.6K ﹤0.01% 2712
2025
Q2 		$243K Buy
41,336
+41,305
+133,242% +$269K ﹤0.01% 2593
2025
Q1 		$260 Buy
+31
New +$279 ﹤0.01% 3727
2023
Q4 		– Sell
-17
Closed -$223 – 3305
2023
Q3 		$223 Sell
17
-283,174
-100% -$5.18M ﹤0.01% 3484
2023
Q2 		$7.24M Sell
283,191
-48,038
-15% -$1.24M 0.01% 929
2023
Q1 		$8.34M Sell
331,229
-3,313
-1% -$77.8K 0.02% 856
2022
Q4 		$7.69M Sell
334,542
-43,140
-11% -$993K 0.02% 876
2022
Q3 		$8.33M Buy
+377,682
New +$7.31M 0.02% 817

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Russell Investments Group's TMCI Position: Q2 2026 in Review

Russell Investments Group reduced its Treace Medical Concepts (TMCI) stake by 24% in Q2 2026, selling an estimated $5.91K and leaving 6,892 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3753.

Russell Investments Group first reported a position in TMCI in Q3 2022 and has held it in 11 quarters since. The position peaked at $8.34M in Q1 2023. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Russell Investments Group held 6,892 shares of Treace Medical Concepts worth $27.4K as of Q2 2026.
  • Russell Investments Group sold 2,151 Treace Medical Concepts shares in Q2 2026, an estimated $5.91K.
  • Treace Medical Concepts made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3753 holding.
  • Russell Investments Group first reported a position in Treace Medical Concepts in Q3 2022 and has held it in 11 quarters since.
  • Russell Investments Group's Treace Medical Concepts position peaked at $8.34M in Q1 2023.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.